ISCA, CHRYSTEL
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.963
EU - Europa 1.918
AS - Asia 1.706
SA - Sud America 315
AF - Africa 69
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 4
Totale 6.990
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.886
IT - Italia 648
SG - Singapore 482
CN - Cina 421
IE - Irlanda 254
GB - Regno Unito 240
BR - Brasile 220
VN - Vietnam 200
HK - Hong Kong 194
DE - Germania 173
SE - Svezia 153
FR - Francia 83
RU - Federazione Russa 76
IN - India 75
FI - Finlandia 71
KR - Corea 52
ID - Indonesia 45
CA - Canada 42
AR - Argentina 34
TR - Turchia 34
JP - Giappone 29
IQ - Iraq 27
EG - Egitto 26
LT - Lituania 26
NL - Olanda 26
TW - Taiwan 23
MX - Messico 22
UA - Ucraina 22
BG - Bulgaria 21
CO - Colombia 20
BD - Bangladesh 19
BE - Belgio 18
ES - Italia 18
PL - Polonia 18
MY - Malesia 17
PK - Pakistan 17
AU - Australia 15
CZ - Repubblica Ceca 14
CL - Cile 13
ZA - Sudafrica 12
EC - Ecuador 11
AE - Emirati Arabi Uniti 10
AT - Austria 9
SA - Arabia Saudita 9
MD - Moldavia 8
MA - Marocco 7
VE - Venezuela 7
JO - Giordania 6
KE - Kenya 6
SY - Repubblica araba siriana 6
NP - Nepal 5
BH - Bahrain 4
DZ - Algeria 4
EU - Europa 4
GR - Grecia 4
HR - Croazia 4
PE - Perù 4
PH - Filippine 4
PY - Paraguay 4
RO - Romania 4
SK - Slovacchia (Repubblica Slovacca) 4
UZ - Uzbekistan 4
CH - Svizzera 3
DO - Repubblica Dominicana 3
EE - Estonia 3
ET - Etiopia 3
HU - Ungheria 3
KG - Kirghizistan 3
OM - Oman 3
PS - Palestinian Territory 3
TH - Thailandia 3
TN - Tunisia 3
AL - Albania 2
AZ - Azerbaigian 2
BB - Barbados 2
GA - Gabon 2
GH - Ghana 2
IR - Iran 2
IS - Islanda 2
JM - Giamaica 2
KH - Cambogia 2
NO - Norvegia 2
PR - Porto Rico 2
PT - Portogallo 2
QA - Qatar 2
RS - Serbia 2
SI - Slovenia 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
DM - Dominica 1
HN - Honduras 1
HT - Haiti 1
IL - Israele 1
KZ - Kazakistan 1
LU - Lussemburgo 1
Totale 6.987
Salva come PNG Salva come JPEG
Città #
Ashburn 382
Santa Clara 317
Singapore 276
Chandler 255
Dublin 251
Hong Kong 186
Fairfield 179
San Jose 170
Dallas 131
Beijing 105
Nyköping 99
Hefei 98
Houston 78
Southend 77
London 71
New York 70
Woodbridge 67
Los Angeles 66
Helsinki 64
Ann Arbor 63
Seattle 59
Ho Chi Minh City 58
Modena 53
Milan 49
Wilmington 49
Cambridge 48
Seoul 47
Council Bluffs 45
The Dalles 45
Bologna 42
Dearborn 39
Hanoi 39
Chicago 31
Jakarta 31
Munich 31
Fremont 29
Lauterbourg 28
Frankfurt am Main 26
Redwood City 26
Shanghai 26
Rome 24
Moscow 23
San Diego 23
Tokyo 22
Orem 21
Sofia 21
São Paulo 21
Princeton 20
Baghdad 19
Asyut 18
Bremen 16
Parma 16
Portsmouth 16
Toronto 16
San Giuliano Milanese 15
Banqiao 14
Jacksonville 14
Mumbai 14
Reggio Emilia 14
Des Moines 13
Warsaw 13
Brooklyn 12
Brussels 12
Da Nang 12
Dong Ket 12
Haiphong 12
Lawrence 12
Eugene 11
Madrid 11
Nuremberg 11
Poplar 11
Sassuolo 11
Columbus 10
Denver 10
Izmir 10
Phoenix 10
Belo Horizonte 9
Brno 9
Castelvetrano 9
Düsseldorf 9
Guangzhou 9
Mexico City 9
Paris 9
Absecon 8
Atlanta 8
Cardiff 8
Chennai 8
Chisinau 8
Manchester 8
Redondo Beach 8
Schiffdorf 8
Amsterdam 7
Buffalo 7
Melbourne 7
Porto Alegre 7
Santorso 7
Cairo 6
Genoa 6
Harbin 6
Istanbul 6
Totale 4.532
Salva come PNG Salva come JPEG
Nome #
Cancer Treatment Induced Bone Loss (CTIBL) in breast cancer women: a multidisciplinary approach at the Modena Cancer Center screening over 600 patients. 594
Endocrine sensitive metastatic breast cancer and bone only disease: are the new treatments always better? 448
Differential molecular pathways expression in HER2 positive early breast cancer according to hormone receptor status. 373
Impact of body composition parameters on tumor response to neoadjuvant chemotherapy in operable breast cancer patients. 344
Clinical Prognosticators in Patients Treated with CDK 4/6 Inhibitors for Hormone Receptors Positive Advanced Breast Cancer 344
Modulation of Mutational Landscape in HER2-Positive Breast Cancer after Neoadjuvant Chemotherapy 309
First-Line Treatment for Endocrine-Sensitive Bone-Only Metastatic Breast Cancer: Systematic Review and Meta-analysis 300
Endocrine-based targeted combination versus endocrine therapy alone as first-line treatment in elderly patients with hormone receptor-positive advanced breast cancer: Meta-analysis of phase II and III randomized clinical trials. 288
Clinical-Pathological Characteristics of HER2+ Breast Cancers patients among BRCA1/2+ carriers tested in Modena Cancer Center. 281
Two-month stop in mammographic screening significantly impacts on breast cancer stage at diagnosis and upfront treatment in the COVID era 271
Predictive Role Of Body Composition Parameters In Operable Breast Cancer Patients Treated With Neoadjuvant Chemotherapy. 263
CLINICAL AND PATHOLOGICAL FEATURES OF BREAST CANCER IN PATIENTS WITH SYSTEMIC SCLEROSIS: PRELIMINARY DATA FROM THE SCLERO-BREAST STUDY 261
First-line treatment for endocrine sensitive bone-only metastatic breast cancer: Is more always better? 251
Clinical and Pathological Features of Breast Cancer in Systemic Sclerosis: Results from the Sclero-Breast Study 249
PROGNOSIS AND RESPONSE TO NEOADJUVANT CHEMOTHERAPY ACCORDING TO HER2 EXPRESSION IN EARLY BREAST CANCER: a retrospective single institution analysis 247
First-line treatment for endocrine sensitive bone-only metastatic breast cancer: Is more always better? 245
Combined endocrine approaches vs endocrine therapy alone as first line treatment in elderly patients with hormone receptor-positive, HER2 negative, advanced breast cancer: To prescribe for the patient or the physician? A meta-analysis of phase II and III randomized clinical trials 241
Primary treatment strategy in elderly patients with hormone receptor positive early breast cancer: is breast cancer surgery. 233
Adjuvant exemestane or tamoxifen plus ovarian suppression in premenopausal women: single institution analysis 222
Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients. 210
T-DM1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis 202
Next Generation Sequencing (NGS): a possible game changer in metastatic breast cancer 201
Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affectclinical outcome of metastatic breast cancer patients 187
Thyroid function impairment after chemo-immunotherapy for advanced NSCLC: A single institutional retrospective report 174
Extracellular vesicles-derived miR-21 as a biomarker for early diagnosis and tumor activity in breast cancer subtypes 162
TDM-1 efficacy in trastuzumabpertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis 150
Combined endocrine approaches vs endocrine therapy alone as first line treatment in elderly patients with hormone receptor-positive, HER2 negative, advanced breast cancer: to prescribe for the patient or the physician? A meta-analysis of phase II and III randomized clinical trials. BMC Cancer 3
Totale 7.053
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.272
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.272
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202183 0 0 0 0 0 0 0 0 0 0 12 71
2021/2022526 57 41 33 28 20 46 20 24 47 53 95 62
2022/2023978 79 121 58 82 80 79 16 70 300 29 32 32
2023/2024605 28 25 51 65 59 75 76 57 33 30 53 53
2024/20251.493 45 18 36 104 273 202 129 111 166 103 118 188
2025/20262.435 198 79 270 256 376 163 358 149 241 284 61 0
Totale 7.053